SL

Sarah Luppino

Investor at M Ventures

Barcelona, Catalonia

Overview 

Sarah Luppino is an Investor at M Ventures, specializing in technology investments with a focus on sustainability, frontier tech, and semiconductors. With a background in chemistry and a Doctor of Philosophy from Massachusetts Institute of Technology, she has successfully invested in companies like Concerto Biosciences (Series A) and holds board positions at various organizations, showcasing her expertise in venture capital and strategic decision-making.

Work Experience 

  • Principal, Technology Investments

    2021 - Current

    Investment focus: Semiconductors, Sustainability & Frontier Technology

  • Board Director

    2024

  • Board Director

    2023

  • Board Director

    2022

Concerto Biosciences reinvents humanity's relationship with microbes.

Raised $26,006,949.00 from Springboard Enterprises.

  • Board Director

    2022

Altoida is creating a new gold standard in brain health with Precision Neurology.

Raised $24,749,815.00 from M Ventures, VI Partners, Alpana Ventures, b2venture, Whitecap Venture Partners, FYRFLY Venture Partners, Hikma Ventures and HonorHealth.

  • Board Observer

    2022

Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.

Raised $22,756,543.00 from Pace Ventures, TRAC, Metaplanet, Ultratech Capital Partners and TRAC.

  • Strategy Consultant

    2018 - 2020

  • Energy & Sustainability Analyst

    2017 - 2018

Articles About Sarah

Relevant Websites